As Antibiotics Recover, Centrient Maintains Focus On Sustainability
CEO Discusses Antibiotics Market, AMR, Manufacturing And European Pressures
As the antibiotics market recovers in the wake of the COVID-19 pandemic, Centrient CEO Rex Clements talks to Generics Bulletin about the firm’s recent sustainability milestones as well as the cost and policy challenges faced by European manufacturing.
